Building the world’s largest biobank with data from global populations to accelerate biomarker and drug discovery and development of next-generation diagnostics.
Secured $25M in funding from F-Prime, Helios Digital Ventures, Digitalis Ventures, CEI Ventures, AME Cloud, Alexandria, Founders Collective, Stanford President’s Fund, and HBM Genomics.
March 27, 2025 -- Galatea Bio, a leader in AI-driven genomic research and clinical genetic testing has secured $25 million in funding to drive discove